Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Colmenero, J. (Jordi) | - |
| dc.creator | Rodriguez, M. (Manuel) | - |
| dc.creator | Salcedo, M. (Magdalena) | - |
| dc.creator | Arias-Milla, A. (Ana) | - |
| dc.creator | Muñoz-Serrano, A. (Alejandro) | - |
| dc.creator | Graus, J. (Javier) | - |
| dc.creator | Nuño, J. (Javier) | - |
| dc.creator | Gastaca, M. (Mikel) | - |
| dc.creator | Bustamante-Schneider, J. (Javier) | - |
| dc.creator | Cachero, A. (Alba) | - |
| dc.creator | Lladó, L. (Laura) | - |
| dc.creator | Caballero, A. (Aránzazu) | - |
| dc.creator | Fernández-Yunquera, A. (Ainhoa) | - |
| dc.creator | Loinaz, C. (Carmelo) | - |
| dc.creator | Fondevila, C. (Constantino) | - |
| dc.creator | Navasa, M. (Miquel) | - |
| dc.creator | Iñarrairaegui, M. (Mercedes) | - |
| dc.creator | Castells, L. (Lluis) | - |
| dc.creator | Pascual, S. (Sonia) | - |
| dc.creator | Ramírez, P. (Pablo) | - |
| dc.creator | Vinaixa, C. (Carmen) | - |
| dc.creator | González-Dieguez, M.L. (María Luisa) | - |
| dc.creator | González-Grande, R. (Rocío) | - |
| dc.creator | Hierro, L. (Loreto) | - |
| dc.creator | Nogueras, F. (Flor) | - |
| dc.creator | Otero, A. (Alejandra) | - |
| dc.creator | Álamo, J.M. (José María) | - |
| dc.creator | Blanco-Fernández, G. (Gerardo) | - |
| dc.creator | Fábrega, E. (Emilio) | - |
| dc.creator | García-Pajares, F. (Fernando) | - |
| dc.date.accessioned | 2024-02-09T11:12:04Z | - |
| dc.date.available | 2024-02-09T11:12:04Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Colmenero, J. (Jordi); Rodriguez, M. (Manuel); Salcedo, M. (Magdalena); et al. "Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients". Journal of Hepatology. 74, 2021, 148 - 155 | es |
| dc.identifier.issn | 0168-8278 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/68976 | - |
| dc.description.abstract | In liver transplant patients, chronic immunosuppression increases the risk of acquiring COVID-19 but it could reduce disease severity. Com- plete immunosuppression with- drawal may not be justified. However, mycophenolate withdrawal or tem- porary conversion to calcineurin inhibitors or everolimus until disease resolution could be beneficial in hos- pitalised patients. | es_ES |
| dc.description.sponsorship | The Spanish Society of Liver Transplantation (SETH) was the only funding agent and covered the fee of an expert English language reviewer. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.rights | info:eu-repo/semantics/closedAccess | es_ES |
| dc.subject | Materias Investigacion::Ciencias de la Salud::Hepatología | es_ES |
| dc.subject | COVID-19 | es_ES |
| dc.subject | SARS-CoV-2 | es_ES |
| dc.subject | Pneumonia | es_ES |
| dc.subject | Epidemiology | es_ES |
| dc.subject | Transplantation | es_ES |
| dc.subject | Immunosuppression | es_ES |
| dc.subject | Mycophenolate | es_ES |
| dc.subject | Calcineurin inhibitors | es_ES |
| dc.subject | Tacrolimus | es_ES |
| dc.subject | Ever- olimus | es_ES |
| dc.subject | Standardised incidence | es_ES |
| dc.subject | Standardised mortality | es_ES |
| dc.title | Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.identifier.doi | 10.1016/j.jhep.2020.07.040 | - |
| dadun.citation.endingPage | 155 | es_ES |
| dadun.citation.publicationName | Journal of Hepatology | es_ES |
| dadun.citation.startingPage | 148 | es_ES |
| dadun.citation.volume | 74 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
